11-2768888-T-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.1559T>G(p.Met520Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M520I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
 - Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
 - Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
 - atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
 - short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
 - familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD4 exome Cov.: 31 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Long QT syndrome    Pathogenic:2 
Variant summary: KCNQ1 c.1559T>G (p.Met520Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251404 control chromosomes (gnomAD). c.1559T>G has been reported in the literature in multiple individuals affected with Long QT Syndrome and this variant co-segregated with the disease (Imboden_2006, Schmitt_2007). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and this variant affected protein function. The following publications have been ascertained in the context of this evaluation (PMID: 22293141, 17192539, 17482572). ClinVar contains an entry for this variant (Variation ID: 52993). Based on the evidence outlined above, the variant was classified as pathogenic. -
This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 520 of the KCNQ1 protein (p.Met520Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT syndrome (PMID: 17482572, 22456477, 22949429, 26669661). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 52993). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 17482572). For these reasons, this variant has been classified as Pathogenic. -
Long QT syndrome 1    Pathogenic:1 
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative, loss of function and gain of function are known mechanisms of disease in this gene. Gain of function variants result exclusively in short QT syndrome (MIM#609621), while dominant negative and loss of function variants can cause long QT syndrome (LQTS, MIM#192500), atrial fibrillation (MIM#607554) and Jervell and Lange-Nielsen syndrome (JLNS, MIM#220400) (OMIM, PMIDs: 19632626, 28438721). (I) 0108 - This gene is known to be associated with both recessive and dominant disease. JLNS is characterized by congenital, bilateral deafness and variable degrees of QT prolongation, and is the only condition caused by biallelic variants (PMID: 28438721). (I) 0112 - The condition associated with this gene has incomplete penetrance (OMIM, PMID: 20301308). (I) 0200 - Variant is predicted to result in a missense amino acid change from methionine to arginine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated C-terminal domain (Uniprot). (I) 0710 - Other missense variants comparable to the one identified in this case have inconclusive previous evidence for pathogenicity. Two alternative changes to a threonine and an isoleucine have been reported as VUS (ClinVar). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in multiple individuals with long QT syndrome (ClinVar, PMID: 17470695,17482572). (SP) 0903 - This variant has limited evidence for segregation with disease. The variant has been reported to segregate with LQTS in an affected family (PMID: 17482572). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional study demonstrated the variant leads to ER retention and dysfunctional trafficking of the mutant channel (PMID: 17482572). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
not provided    Pathogenic:1 
Identified in several individuals with LQTS referred for genetic testing at GeneDx and in published literature (PMID: 17482572, 17470695, 19716085, 28479515); Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate an intracellular trafficking defect and channel loss of function, resulting in haploinsufficiency (PMID: 17482572); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22949429, 17470695, 19716085, 19841300, 26344792, 28479515, 22456477, 26669661, 17482572, 31737537) -
Cardiovascular phenotype    Pathogenic:1 
The p.M520R variant (also known as c.1559T>G), located in coding exon 12 of the KCNQ1 gene, results from a T to G substitution at nucleotide position 1559. The methionine at codon 520 is replaced by arginine, an amino acid with similar properties, and is located in the C-terminal cytoplasmic region. This alteration has been reported in individuals with long QT syndrome (LQTS) and has been described to segregate with LQTS in an affected family (Moss AJ et al. Circulation, 2007 May;115:2481-9; Schmitt N et al. Biochem. Biophys. Res. Commun., 2007 Jun;358:304-10; Kapa S et al. Circulation, 2009 Nov;120:1752-60). In a study of LQTS clinical genetic testing, this alteration was reported in three patients; however, clinical details were limited (Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303). In addition, in vitro studies have demonstrated that this variant leads to protein trafficking defects and loss of potassium channel function (Schmitt N et al. Biochem. Biophys. Res. Commun., 2007 Jun;358:304-10). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Congenital long QT syndrome    Other:1 
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:17482572;PMID:19716085;PMID:19841300;PMID:17470695). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at